Literature DB >> 1174915

Letter: Brain abscess.

H R Ingham, J B Selkon, S C So, R Weiser.   

Abstract

Mesh:

Substances:

Year:  1975        PMID: 1174915      PMCID: PMC1674743          DOI: 10.1136/bmj.4.5987.39-a

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  5 in total

1.  Treatment with metronidazole of three patients with serious infections due to Bacteroides fragilis.

Authors:  H R Ingham; G E Rich; J B Selkon; J H Hale; C M Roxby; M J Betty; R W Johnson; P R Uldall
Journal:  J Antimicrob Chemother       Date:  1975-06       Impact factor: 5.790

2.  Endocrine ophthalmopathy.

Authors:  I D Ramsay
Journal:  Br Med J       Date:  1968-12-14

3.  Inadequate antibody response to HBAg or suppressor T-cell defect in development of active chronic hepatitis.

Authors: 
Journal:  Lancet       Date:  1974-12-28       Impact factor: 79.321

4.  Metronidazole versus anaerobes. In vitro data and initial clinical observations.

Authors:  F P Tally; V L Sutter; S M Finegold
Journal:  Calif Med       Date:  1972-12

5.  Metronidazole for Crohn's disease.

Authors:  B Ursing; C Kamme
Journal:  Lancet       Date:  1975-04-05       Impact factor: 79.321

  5 in total
  3 in total

1.  Artifactual depression of serum glutamic oxaloacetic transaminase by metronidazole.

Authors:  J P Rissing; C Newman; W L Moore
Journal:  Antimicrob Agents Chemother       Date:  1978-10       Impact factor: 5.191

2.  Access of metronidazole into the chronically inflamed middle ear with reference to anaerobic bacterial infections.

Authors:  L Jokipii; P Karma; A M Jokipii
Journal:  Arch Otorhinolaryngol       Date:  1978-06-27

3.  Cerebrospinal fluid concentrations of metronidazole, tinidazole and ornidazole in rabbits.

Authors:  A M Jokipii; L Jokipii
Journal:  Infection       Date:  1980       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.